What type of study is this?

September 22, 2025

Association of Lifetime Psychiatric Comorbidity and Current Substance Use in Methadone-Treated Individuals with Opioid Use Disorders.

View Full Paper

Ask AI

Bookmark

Authors

GBGabriela BarbagliaUniversitat Pompeu Fabra JMJavier Molero-CalafellUniversitat Pompeu Fabra AAAriadna Angulo-BrunetUniversitat Oberta de Catalunya

Discussion

Member takes

Implication

Observational analysis explores links between psychiatric comorbidity and substance use in individuals undergoing opioid agonist treatment, suggesting diverse influences.

Key Points

Psychiatric comorbidity was linked only to cannabis use among patients undergoing methadone treatment, showing significant interaction.
Of the sampled patients, 63.5% had a lifetime dual diagnosis, while 83.5% reported current substance use in the past month.
Analysis utilized Poisson regression on a sample of 588 patients receiving outpatient drug treatment with various sociodemographic adjustments.
Results suggest existing treatment approaches and methadone's pharmacological effects may mitigate broader substance use associations.

Cite This Study

Barbaglia et al. (2025) studied this question.

synapsesocial.com/papers/68d46fd431b076d99fa6a2f7 https://doi.org/10.1080/15504263.2025.2557191

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis explores links between psychiatric comorbidity and substance use in individuals undergoing opioid agonist treatment, suggesting diverse influences.

Association of Lifetime Psychiatric Comorbidity and Current Substance Use in Methadone-Treated Individuals with Opioid Use Disorders.

Discussion

Member takes

Implication

Key Points

Cite This Study

Association of Lifetime Psychiatric Comorbidity and Current Substance Use in Methadone-Treated Individuals with Opioid Use Disorders.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider